中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2012年
2期
177-178
,共2页
陈绍奉%安维哨%薛盛龙%徐上淼%缪克强%王俊道
陳紹奉%安維哨%薛盛龍%徐上淼%繆剋彊%王俊道
진소봉%안유초%설성룡%서상묘%무극강%왕준도
心房颤动%阿托伐他汀%替米沙坦%C反应蛋白
心房顫動%阿託伐他汀%替米沙坦%C反應蛋白
심방전동%아탁벌타정%체미사탄%C반응단백
Atrial fibrillation%Atorvastatin%Telmisartan%C-reactive protein
目的 观察阿托伐他汀联合替米沙坦治疗特发性阵发性心房颤动的疗效.方法 将70例特发性阵发性心房颤动患者随机分为观察组与对照组各35例.观察组采用阿托伐他汀联合替米沙坦治疗,对照组单用替米沙坦治疗,治疗并随访半年,对比观察两组患者疗效,分析两组患者用药前后血浆C反应蛋白(CRP)和心律失常发作情况.结果 治疗后患者症状均有不同程度改善,观察组有效率(88.6%)显著高于对照组(68.6%),CRP含量显著低于对照组(均P<0.05).结论 阿托伐他汀联合替米沙坦治疗特发性阵发性心房颤动优于单一替米沙坦治疗,能较好改善临床症状.
目的 觀察阿託伐他汀聯閤替米沙坦治療特髮性陣髮性心房顫動的療效.方法 將70例特髮性陣髮性心房顫動患者隨機分為觀察組與對照組各35例.觀察組採用阿託伐他汀聯閤替米沙坦治療,對照組單用替米沙坦治療,治療併隨訪半年,對比觀察兩組患者療效,分析兩組患者用藥前後血漿C反應蛋白(CRP)和心律失常髮作情況.結果 治療後患者癥狀均有不同程度改善,觀察組有效率(88.6%)顯著高于對照組(68.6%),CRP含量顯著低于對照組(均P<0.05).結論 阿託伐他汀聯閤替米沙坦治療特髮性陣髮性心房顫動優于單一替米沙坦治療,能較好改善臨床癥狀.
목적 관찰아탁벌타정연합체미사탄치료특발성진발성심방전동적료효.방법 장70례특발성진발성심방전동환자수궤분위관찰조여대조조각35례.관찰조채용아탁벌타정연합체미사탄치료,대조조단용체미사탄치료,치료병수방반년,대비관찰량조환자료효,분석량조환자용약전후혈장C반응단백(CRP)화심률실상발작정황.결과 치료후환자증상균유불동정도개선,관찰조유효솔(88.6%)현저고우대조조(68.6%),CRP함량현저저우대조조(균P<0.05).결론 아탁벌타정연합체미사탄치료특발성진발성심방전동우우단일체미사탄치료,능교호개선림상증상.
Objective To investigate the clinical efficacy of Telmisartan combined with Atorvastatin in treating patients with idiopathic paroxysmal atrial fibrillation(IPAF).Methods 70 cases of IPAF were randomly divided into study group(given treatment of Telmisartan combined with Atorvastatin)and control group(given treatment of Telmisartan),35 cases in each group,all patients got 2 years follow-up visit.The change of CRP and the arrhythmia recurrence were observed after treatment.Results After surgery,patients were better than before,but the efficiency in study group was significantly higher than control group(88.6% vs 68.6%,P <0.05);CRP of the two groups were significantly reduced after treatment,two groups have significant difference(P < 0.05).Conclusion Curative effect of atorvastatin combined with telmisartan on IPAF is better than that of telmisartan treatment and clinical implementation should be promoted.